Skip to main content
International Journal of Clinical and Experimental Pathology logoLink to International Journal of Clinical and Experimental Pathology
. 2017 Sep 1;10(9):9951–9959.

Genetic effects on hypertriglyceridemic waist phenotype: rs780094, rs10830963, rs151290, and rs972283 polymorphisms and the interactions between them and behavior risk factors

Jinjin Wang 1, Jianfeng Zhang 2, Jianna Li 3, Zichen Liu 3, Kaiping Gao 3
PMCID: PMC6965957  PMID: 31966885

Abstract

Backgrounds: We aimed to evaluate the association of SNPs in GCKR, MTNR1B, KCNQ1, and KLF14 genes confirmed in previous studies and hapertriglyceridemic waist (HTGW) in Han Chinese, and assess the interactions between genes and behavior risk factors. Methods: We genotyped the single nucleotide polymorphisms (SNPs) for GCKR, MTNR1B, KCNQ1, and KLF14 gene were genotyped in 373 patients with HTGW and 466 normal healthy subjects. We used logistic regression to investigate the gene-gene, gene-behavior interactions for the risk of HTGW. Results: Among the 4 SNPs, the AG genotype of rs780094 was protective factor, whereas the recessive model of rs151290 was risk factor after adjusting for confounders. Stratified by sex, only for women, the recessive model of rs151290 was still significance. The significant synergies interactions between SNPs were found between rs780094 in GCKR and rs972283 in KLF14 and rs10830963 in MTNR1B, respectively; meanwhile, the antagonistic interaction was revealed for rs151290 and rs780094 only for women. For male, there were significant synergies interactions between rs780094, smoking and alcohol drinking; and antagonistic interaction was revealed between rs780094 and severe activity both for men and women. Conclusions: GCKR and KLF14 genes play a significant role in risk of HTGW in a Han Chinese population.

Keywords: Polymorphisms, HTGW, Chinese, interaction

Introduction

As a marker of the atherogenic metabolic triad in man, hypertriglyceridemic waist (HTGW) was first proposed in 2000 [1]. A meta-analysis published in 2015 showed that the prevalence of HTGW ranged from 4% to 47% in different countries, and the pooled prevalence was 18% (95% CI, 13-23%) [2]. HTGW is a specific metabolic abnormality associated with type 2 diabetes, cardiovascular risk, impaired glucose tolerance and increased insulin resistance [3-6]. It is noteworthy that HTGW has spreading to schoolchildren and adolescents [7,8]. However, the main reason for the non-effective implementation of prevention and control, the etiology and the mechanisms of HTGW remain uncertain. Through genetic analysis to discover the candidate gene associated with HTGW is and effective method to reveal the exact pathogenesis of this metabolic abnormal phenotype.

The genetic evidences for HTGW phenotype are relatively rare. One study published in 2015 investigated 19 fasting insulin-associated single nucleotide polymorphisms (SNPs), and the results showed that glucokinase regulatory protein (GCKR) was an independent risk factor because of its primary effect on body mass index (BMI), triglycerides (TG) and high-density lipoprotein-cholesterol (HDL-C). The GCKR variant is likely to affect glucose and lipid metabolism in the liver and is significantly associated with multiple liver-based phenotypes [9]. Recently, lots of studies have evaluated the associations between type 2 diabetes (T2DM) and HTGW, and obtained the positive answers [2,3,10-13]. Our previous meta-analysis including 6 studies showed that the rs151290 in voltage-gated channel KQT-like subfamily, member 1 (KCNQ1) and rs972283 in Krüppel-like factor 14 (KLF14) were both associated with increased risk of type 2 diabetes, and another meta-analysis also proved the association between rs10830963 in melatonin receptor 1B (MTNR1B) and rs780094 in GCKR and type 2 diabetes [14].

To sum up, we hypothesized that these four genes are associated with HTGW. Therefore, we aimed to evaluate the association of SNPs in GCKR, MTNR1B, KCNQ1, and KLF14 genes confirmed in previous studies (Table 1, all SNPs’ MAF was above 0.05 in Han Chinese based on the International HapMap Project) and HTGW in Han Chinese, and assess the interactions between genes and behavior risk factors.

Table 1.

The single nucleotide polymorphisms (SNPs) selected for study

Gene SNPs Alleles Ancestral Allele MAF*
GCKR rs780094 A/G G 0.366
MTNR1B rs10830963 C/G C 0.366
KCNQ1 rs151290 A/C A 0.433
KLF14 rs972283 A/G G 0.333
*

MAF minor allele frequencies in Han Chinese people.

Materials and methods

We used the case-control design to investigate the associations with HTGW.

All participants signed the informed consents, and the study was approved by the Ethics Committees of the First Affiliated Hospital of Henan University of Traditional Chinese Medicine.

Patients and controls

All participants were from local inhabitants of Henan Province shared the same Han Chinese ancestry (confirming by People’s Republic of China resident identity card). A total of 373 cases first diagnosed with HTGW were recruited from the outpatient clinics in four different hospitals. HTGW was diagnosed based on the International Diabetes Federation criteria for metabolic syndrome and the WHO criteria for central obesity for Asian populations, which were defined as a waist circumference (WC) of 85 cm or more in men, a WC of 80 cm or more in women, and a triglyceride level of 1.70 mmol/L or more [15,16]. 466 healthy controls were recruited from the same clinics. We used the PGA package, for the condition: Disease prevalence in China, 2.8 [17]; the lowest MAT in Chinese among these four SNPs, 0.333; α = 0.05; 1/β = 0.85; case to control ratio, 1:4. The exclusion criteria for participants in our study included pregnant women; handicapped; or mentally disturbed; cancer patients; obesity caused by other diseases or drugs intake; and unable or unwilling to participate.

Biochemical and anthropometry measurements

All blood samples were combined after a minimum 8-hour fasting with disodium non-EDTA for measuring total cholesterol (TC), triglyceride (TG), and high-density lipoprotein-cholesterol (HDL-C) by using an automatic biochemical analysis instrument. Low-density lipoprotein-cholesterol (LDL-C) was calculated by the Freidwald formula [18]. Body weight, height, WC (The study object to keep upright, arms naturally drooping, relax the abdomen, the weight will be evenly distributed in the legs, legs were merged state, to maintain normal breathing, breathing should be measured smoothly, do not intentionally breath or abdomen; Measurement of the position above the navel 1 cm, the level of measurement, the measurement tape to be in direct contact with the skin, banned underwear or single clothing across the measurement. Record the readings at the end of each inspiration and accurate to 0.5 cm), and blood pressure (systolic and diastolic: SBP and DBP) were collected as anthropometric data. The behavioral risk factors (including smoking, alcohol drinking, and physical activity) were collected by interviewer-administered questionnaire. Smoking was divided into two smoking group by collecting information about cigarettes and hand-rolled cigarettes: smoking cessation groups (those who have quit for more than one year) and non-smoking group. The subjects were divided into two groups, including non-alcohol and drinking group who are drinking liquor in the past 12 months. Physical activity was divided into three groups according to the nature of the work mainly engaged in, including mild physical activity group (to sit or station-based: exp. the sale of the store) and moderate physical activity group (motorists, electricians, fitters, metalworkers, carpenters, etc.), and severe physical activity groups (manual handling, construction, construction, repair, etc.) (Table 2).

Table 2.

Behavior risk factors’ distributions for cases with HTGW and controls

Behavior Controls (%) Cases (%) P value
Smoking
    Non-smoking 277 (74.3) 321 (68.9) 0.092
    Smoking 96 (25.7) 145 (31.1)
Drinking
    Non-alcohol 312 (83.6) 406 (87.3) 0.138
    Drinking 61 (16.4) 59 (12.7)
Activity
    Mild 159 (34.1) 213 (57.1) < 0.001
    Moderate 74 (15.9) 39 (10.5)
    Severe 233 (50.0) 121 (32.4)

Genotyping

We extracted genomic DNA from whole blood by using the blood genome DNA extraction kit (Laifeng BIO, Zhengzhou, China). Genotyping was performed by using TaqMan SNP Genotyping Fluorescence quantitative assays (Applied Biosystems, Foster City, CA, USA) in 2014. PCR was carried out on a GeneAmp PCR system 7000, and fluorescence was detected on an ABI PRISM 7000 sequence detector (Applied Biosystems). The TaqMan Fluorescence SNP probes were synthesized by Life Technologies Biotech Co. (Foster, CA, USA). Overall, genotyping success rate was 100%. To verify the reproducibility, we repeated 20% of samples at random as a quality control for genotyping, and the concordance rate was 100% (data not shown).

Statistical analysis

Statistical analyses were performed with SPSS v21.0 for Windows (SPSS Inc., Chicago, IL, USA). Chi-square test was used to analyze the categorical variables which are presented as the number and percentage. Student t-test was used to analyze the continuous variables which are presented by mean and standard deviation. The Hardy_Weinberg equilibrium was calculated in controls using Haploview 4.2. The odds ratios (ORs), 95% confidence intervals (95% CIs) and corresponding P values for risk of HTGW were evaluated by logistic regression analysis after adjusting for gender, age, blood pressure, and behavioral risk factors (including smoking, alcohol consumption, and physical activity). The interaction terms between two variables were assessed by logistic regression models to evaluate the interactions between these 4 SNP and behavioral risk factors (involving alcohol, smoking, and physical activity) by adjusting gender, age and blood pressure. P < 0.05 was considered statistically significant. Power calculation was performed by PGA software (http://dceg.cancer.gov/bb/tools/pga).

Quality control

Investigators and laboratory operators were trained. All biochemical tests are performed in the same laboratory, and 20% of the samples at random were repeated.

Results

Clinical characteristics of the study participants

Totally, our study recruited 839 participants including 373 HTGW cases (164 males and 209 females) and 466 controls (270 males and 196 females). Compared with controls, HTGW patients had significantly greater anthropometric and metabolic values (P < 0.001; Table 3).

Table 3.

Characteristics of patients with HTGW and controls in a Han Chinese population

Characteristics Control (n = 466) Case (n = 373) P value
Sex
    Male 270 (57.90) 164 (44.00) < 0.001
    Female 196 (42.10) 209 (56.00)
Age (years) 47.62±12.229 52.98±11.252 < 0.001
Body mass index (kg/m2) 22.82±3.075 29.14±4.255 < 0.001
Waist circumference (cm) 76.34±6.408 99.05±14.506 < 0.001
SBP (mmHg) 121.25±17.521 132.34±18.211 < 0.001
DBP (mmHg) 71.39±10.581 77.65±11.941 < 0.001
Fasting plasma glucose (mmol/l) 5.78±1.941 7.30±3.095 < 0.001
HDL-C (mmol/l) 1.21±0.262 1.07±0.210 < 0.001
LDL-C (mmol/l) 2.55±0.690 3.00±0.995 < 0.001
TG (mmol/l) 1.08±0.320 2.98±1.478 < 0.001
TC (mmol/l) 4.22±0.798 5.18±1.112 < 0.001

SBP: systolic blood pressure; DBP: diastolic blood pressure; HDL-C: high-density lipoprotein-cholesterol; LDL-C: low-density lipoprotein-cholesterol; TG: triglycerides; TC: total cholesterol.

Association of four SNPs with HTGW

Among these four SNPs, the frequencies had no differences between cases and controls (Table 4). All genotypes were in Hardy-Weinberg equilibrium in controls (P > 0.05). By logistic regression analysis, the AG genotype of rs780094 and the recessive model of rs151290 was associated with HTGW; and the AG genotype of rs780094 was protective factor, whereas the recessive model of rs151290 was risk factor after adjusting for confounders such as sex, age, FPG, SBP, DBP, and behavior risk factors (Table 5). The power for them was about 98% and 96%, respectively. Stratified by sex, the recessive model of rs151290 was still significance for women, with a power about 95% (Table 6).

Table 4.

Genotypic and allelic distributions of SNPs for cases with HTGW and controls in a Han Chinese population

SNPs Controls (%) Cases (%) P value
rs780094
    GG 129 (27.7) 86 (23.1) 0.111
    AG 208 (44.6) 193 (51.7)
    AA 129 (27.7) 94 (25.2)
    G 466 (50.0) 365 (48.9) 0.694
    A 466 (50.0) 381 (51.1)
rs10830963
    CC 174 (37.3) 131 (36.1) 0.302
    GC 214 (45.9) 164 (44.0)
    GG 78 (16.7) 78 (20.9)
    C 562 (60.3) 426 (57.1) 0.194
    G 370 (39.7) 320 (42.9)
rs151290
    AA 59 (12.7) 47 (12.6) 0.153
    CA 208 (44.6) 190 (50.9)
    CC 199 (42.7) 136 (36.5)
    A 606 (65.0) 462 (61.9) 0.202
    C 326 (35.0) 284 (38.1)
rs972283
    GG 234 (50.2) 193 (51.7) 0.889
    GA 190 (40.8) 146 (39.1)
    AA 42 (9.0) 34 (9.1)
    G 658 (70.6) 532 (71.3) 0.787
    A 274 (29.4) 214 (28.7)

Data are number (%).

Table 5.

Association of SNPs and HTGW in Han Chinese

SNPs Genotypes Unadjusted OR (95% CI) P value Adjusted OR* (95% CI) P * value
rs780094 GG 1 - 1 -
AG 1.392 (0.995-1.947) 0.054 0.655 (0.446-0.962) 0.031
AA 1.093 (0.747-1.600) 0.647 1.078 (0.605-1.922) 0.798
AA vs. AG+GG 0.880 (0.646-1.199) 0.419 0.722 (0.454-1.148) 0.169
AA+AG vs. GG 1.277 (0.932-1.750) 0.128 1.524 (0.952-2.439) 0.080
rs10830963 CC 1 - 1 -
GC 1.018 (0.751-1.380) 0.909 0.785 (0.502-1.227) 0.289
GG 1.328 (0.902-1.956) 0.151 1.187 (0.687-2.051) 0.539
GG vs. GC+CC 1.315 (0.928-1.864) 0.123 1.356 (0.831-2.211) 0.223
GG+GC vs. CC 1.101 (0.829-1.462) 0.507 0.895 (0.593-1.351) 0.598
rs151290 AA 1 - 1 -
CA 1.147 (0.745-1.764) 0.533 1.191 (0.610-2.328) 0.609
CC 0.858 (0.552-1.333) 0.496 0.752 (0.377-1.501) 0.419
CC vs. CA+AA 0.770 (0.582-1.018) 0.067 1.089 (0.676-1.752) 0.739
CC+CA vs. AA 1.005 (0.667-1.515) 0.979 1.528 (1.107-2.109) 0.010
rs972283 GG 1 - 1 -
GA 0.932 (0.699-1.242) 0.630 0.824 (0.544-1.249) 0.362
AA 0.981 (0.601-1.603) 0.941 1.011 (0.480-2.129) 0.977
AA vs. GA+GG 1.013 (0.630-1.627) 0.959 1.097 (0.533-2.261) 0.801
AA+GA vs. GG 0.941 (0.716-1.235) 0.660 0.853 (0.575-1.266) 0.430
*

Adjusted for sex, age, FPG, SBP, DBP, and behavior risk factors.

Table 6.

Association of SNPs and HTGW stratified analysis by sex

Sex SNPs Genotypes OR (95% CI) P value
Male rs780094 GG 1 -
AG 0.410 (0.423-1.192) 0.195
AA 0.838 (0.541-1.297) 0.428
AA vs. AG+GG 0.911 (0.558-1.486) 0.709
AA+AG vs. GG 1.333 (0.827-2.150) 0.238
rs10830963 CC 1 -
GC 0.903 (0.568-1.435) 0.666
GG 1.908 (0.611-1.971) 0.755
GG vs. GC+CC 1.162 (0.686-1.966) 0.577
GG+GC vs. CC 0.957 (0.622-1.472) 0.841
rs151290 AA 1 -
CA 1.083 (0.556-2.110) 0.814
CC 0.777 (0.390-1.550) 0.474
CC vs. CA+AA 0.728 (0.474-1.119) 0.148
CC+CA vs. AA 1.556 (0.996-2.433) 0.052
rs972283 GG 1 -
GA 0.964 (0.621-1.495) 0.869
AA 1.164 (0.551-2.459) 0.691
AA vs. GA+GG 1.182 (0.572-2.442) 0.651
AA+GA vs. GG 0.999 (0.660-1.510) 0.995
Female rs780094 GG 1 -
AG 0.545 (0.296-1.003) 0.051
AA 1.343 (0.699-2.578) 0.376
AA vs. AG+GG 0.884 (0.531-1.474) 0.638
AA+AG vs. GG 1.640 (0.938-2.867) 0.083
rs10830963 CC 1 -
GC 0.827 (0.492-1.390) 0.474
GG 1.093 (0.563-2.123) 0.793
GG vs. GC+CC 1.211 (0.664-2.208) 0.531
GG+GC vs. CC 0.898 (0.554-1.455) 0.661
rs151290 AA 1 -
CA 1.382 (0.653-2.923) 0.397
CC 0.711 (0.330-1.532) 0.383
CC vs. CA+AA 0.550 (0.337-0.900) 0.017
CC+CA vs. AA 1.730 (1.053-2.843) 0.031
rs972283 GG 1 -
GA 1.027 (0.627-1.682) 0.915
AA 0.755 (0.331-1.723) 0.505
AA vs. GA+GG 0.746 (0.337-1.654) 0.471
AA+GA vs. GG 0.968 (0.608-1.542) 0.891

Adjusted for age, FPG, SBP, DBP, and behavior risk factors.

Interaction of four SNPs with HTGW

The logistic regression was used to analyze the interactions between pairs of SNPs after adjusting for confounders (such as age, SBP, DBP, and behavior risk factors for all participants and men and women, respectively). The results showed that the significant synergistic interactions between SNPs were genotype AG and AA of rs780094 in GCKR, GA of rs972283 in KLF14, GG genotype of rs10830963 in MTNR1B, respectively. Meanwhile, the antagonistic interaction was revealed for the genotype CC of rs151290 in KCNQ1 and AA of rs780094 in GCKR only for women (Table 7 listed all statistically significant results).

Table 7.

Interactions of genotypes of four single nucleotide polymorphisms (SNPs) for Women HTGW

Group Beta S.E. OR 95% CI P
rs780094 rs10830963
    AG     GG 2.258 1.034 9.568 1.261-72.573 0.029
    AA     GG 2.518 1.116 12.409 1.393-110.564 0.024
rs151290 rs780094
    CC     AA -2.752 1.355 0.064 0.004-0.908 0.042
rs780094 rs972283
    AG     GA 1.686 0.736 5.398 1.275-22.853 0.022
    AA     GA 1.742 0.804 5.708 1.181-27.579 0.030

Adjusted for age, FPG, SBP, DBP, and behavior risk factors.

Interaction of SNPs with behavior risk factors and HTGW

The logistic regression was used to analyze the interactions between SNPs and behavior risk factors and HTGW after adjusting for confounders (such as age, SBP, DBP, and behavior risk factors including drinking, smoking, and activity for men, and for women only analyzing activity because of the data of drinking and smoking too little), respectively. The results showed that for total there were antago nistic interactions between AA genotype of rs780094 and alcohol drinking, and GA genotype of rs972283 and severe activity. For males, there were significant synergistic interactions between AA genotype of rs780094 and smoking, and AA, AG genotypes of rs780094 and alcohol drinking, while antagonistic interactions were revealed between AA genotype of rs780094 and severe activity. For females, there was antagonistic interaction between AA genotype of rs780094 and severe activity (Table 8). A preliminary discussion was performed about interactions in this study, and further study will be needed to verify.

Table 8.

Interaction of behavioral factors and genotypes of single nucleotide polymorphisms (SNPs) for HTGW

Sex Group Beta S.E. OR 95% CI P
Total AA in rs780094 Alcohol -1.883 0.684 0.152 0.040-0.581 0.006
GA in rs972283 Severe Activity -0.811 0.363 0.444 0.218-0.905 0.025
Male AA in rs780094 Cig 1.213 0.597 3.365 1.045-10.834 0.042
AA in rs780094 Alcohol 1.565 0.721 4.783 1.164-19.657 0.030
AA in rs780094 Severe Activity -0.746 4.519 0.474 0.238-0.943 0.034
AG in rs780094 Alcohol 2.307 0.835 10.040 1.955-51.575 0.006
Female AA in rs780094 Severe Activity -0.701 0.324 0.496 0.263-0.937 0.031

Adjusted for age, FPG, SBP, DBP, and behavior risk factors.

Discussion

Waist measurement is the main method for evaluating abdominal obesity estimating the accumulation of visceral adipose tissue [19]. Whereas, triglycerides concentration can indirectly reflect low-density lipoprotein cholesterol level [20]. When both measurements are increasing, it indicates that the body functions for processing residual energy and subcutaneous fat stored are damaged, followed by impaired glucose and lipid metabolism disorders. Some studies have shown that HTGW is associated with increased insulin resistance and excessive activation of beta cell function, and higher HTGW is useful for identifying and early intervention type 2 diabetes [21]. HTGW is the result of environmental factors and genetic factors interaction, and the genetic factors determine the different susceptibility to diabetes between individuals. Under certain environmental triggers action, individuals with high risk genetic variants have more susceptible HTGW. Combined with environmental factors to found and confirm susceptibility loci of HTGW play an important role in preventive measures and reducing the incidence of HTGW. Currently, researches about HTGW are main focusing the relationships between HTGW and cardiovascular and type 2 diabetes. However, evidence about susceptibility genes is rare. Our study provided new evidence indicating that that rs780094 and rs151290 genotypes are associated with HTGW in Han Chinese, especially in women.

In our study, stronger associations of SNPs and HTGW and the interactions between SNPs and HTGW were found in women than in men. This result suggested that gender factor may play important role in estimating the effect of genetic factors on HTGW. In the analysis of metabolism-related indicators, sex differences exist in the relationships among abdominal obesity, obesity related metabolic abnormalities [22]. Our results showed that the interactions between SNPs and HTGW were only found in women. Since women in this survey had less smoking and drink-ing, physical activity showed more significant antagonistic interaction with AA genotype rs780094.

We analyzed the interactions among four SNPs and behavioral factors in two directions, involving synergy which means two or more factors combine greater than additively in relation to risk and antagonism which to the contrary. Among these four SNPs, rs780094 in GCKR gene showed significant association with HTGW both in genetic effect and interactions analyses. GCKR belongs to an isomerase family, and locates on chromosome 2p23 mainly in the liver and pancreatic cells [23]. In liver cells, GCKR gene regulates GCK, and competitively inhibit the binding of glucose and GCK [24]. The results of some researches show that homozygous AA of rs780094 in GCKR gene had lower risk of developing diabetes [25]; A allele showed low risk in the performance of type 2 diabetes, and indicating low levels of fasting blood glucose and high triglycerides [26,27]. Our results showed that AG genotype of rs780094 can reduce the risk of HTGW in independent analysis. Furthermore, AG and AA genotypes of rs780094 combined with GG genotype of rs10830963 in MTNR1B gene and GA genotype of rs972283 in KLF14 gene can significant increased the risk of HTGW (OR: 5.398~12.409). Our data suggests that A allele in rs780094 is associated with increased risk of abnormal lipid metabolism through genetic- interactions’ manner.

Recently, rs972283 in KLF14 was found to be associated with T2DM in an European genome-wide association study. T2DM risk allele at rs972283 in KLF14 was associated with higher fasting insulin, consistent with a primary effect on insulin action [28]. Our previous meta-analysis suggested that rs972283 in KLF14 was associated with increased risk of T2DM [29]. Given the close association between type 2 diabetes and HTGW, we hypothesized that rs972283 may also associated with HTGW. However, our data did not find any evidence of association between C allele of rs972283 and the risk of HTGW. We considered that the ethnicity may be the main reason for the differences, and it is widely known that the MAF of the SNPs change from one group to another, and the structure of LD also changes between different populations.

For chronic non-communicable diseases, lifestyle interventions play a crucial role. The research published in 2016 showed that exercise training has positive effect for maximal fat oxidation intensity on body composition and lipid metabolism in overweight middle-aged women [30]. Our results showed that activity had a positive effect on reducing the risk of HTGW.

Limitations should be pointed out in our study. First, some ORs in our study had very wide 95% CI this may be attributable to a relatively small sample size. Further studies with larger sample sizes are required to confirm the results from the present study. Second, our results did not exclude the possibility of an association between other SNPS in these four genes and the HTGW phenotype, a more detailed tagging SNPs analysis is needed to exclude the influence of other genetic variants on the results. In conclusion, GCKR and KLF14 genes and gene-environment interactions play a significant role in the risk of HTGW in Han Chinese population, especially in women. Further studies in people of different ethnic backgrounds are needed to clarify the mechanisms and underlying genetic effects of HTGW.

Acknowledgements

This study was supported by the Doctoral Research Fund of Henan Chinese Medicine: BSJJ2014-18 and the Natural Science Foundation of Guangdong Province (grant no. S2013010016791), the Medical Science and Technology Research Foundation of Guangdong Province (grant nos. A2016213), the Science and Technology Development Foundation of Shenzhen (grant nos. JCYJ20130326110246234).

Disclosure of conflict of interest

None.

Authors’ contribution

K. Gao and J. Wang designed the study, analyzed data, and drafted the manuscript. J. Wang, J. Li, Z. Liu, and K. Gao conducted data analyses. J. Wang, K. Gao, and J.Li extracted data and performed statistical analyses. J. Wang wrote the manuscript. All authors approved the final manuscript. We sincerely thank all of the authors for their work in this study.

References

  • 1.Lemieux I, Pascot A, Couillard C, Lamarche B, Tchernof A, Almeras N, Bergeron J, Gaudet D, Tremblay G, Prud’Homme D, Nadeau A, Despres JP. Hypertriglyceridemic waist: a marker of the atherogenic metabolic triad (hyperinsulinemia; hyperapolipoprotein B; small, dense LDL) in men? Circulation. 2000;102:179–84. doi: 10.1161/01.cir.102.2.179. [DOI] [PubMed] [Google Scholar]
  • 2.Ren Y, Luo X, Wang C, Yin L, Pang C, Feng T, Wang B, Zhang L, Li L, Yang X, Zhang H, Zhao J, Hu D. Prevalence of hypertriglyceridemic waist and association with risk of type 2 diabetes mellitus: a meta-analysis. Diabetes Metab Res Rev. 2016;32:405–12. doi: 10.1002/dmrr.2725. [DOI] [PubMed] [Google Scholar]
  • 3.Diaz-Santana MV, Suarez PE, Ortiz MA, Guzman SM, Perez CC. Association between the hypertriglyceridemic waist phenotype, prediabetes, and diabetes mellitus among adults in puerto rico. J Immigr Minor Health. 2016;18:102–9. doi: 10.1007/s10903-014-9985-y. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 4.Cabral RA, Feliciano PP, Cristine PM, Goncalves AR, Segheto W, Da SD, Pacheco AM, Zarbato LG. Hypertriglyceridemic waist phenotype and cardiometabolic alterations in Brazilian adults. Nutr Hosp. 2015;32:1099–106. doi: 10.3305/nh.2015.32.3.9305. [DOI] [PubMed] [Google Scholar]
  • 5.Huang J, Zhou C, Li Y, Zhu S, Liu A, Shao X, Liu X, Holthfer H, Zou H. Visceral adiposity index, hypertriglyceridemic waist phenotype and chronic kidney disease in a southern Chinese population: a cross-sectional study. Int Urol Nephrol. 2015;47:1387–96. doi: 10.1007/s11255-015-1040-y. [DOI] [PubMed] [Google Scholar]
  • 6.Moon BS, Park HJ, Lee MK, Jeon WS, Park SE, Park CY, Lee WY, Oh KW, Park SW, Rhee EJ. Increased association of coronary artery calcification in apparently healthy Korean adults with hypertriglyceridemic waist phenotype: the Kangbuk Samsung health study. Int J Cardiol. 2015;194:78–82. doi: 10.1016/j.ijcard.2015.05.104. [DOI] [PubMed] [Google Scholar]
  • 7.Guilherme FR, Molena-Fernandes CA, Hintze LJ, Favero MT, Cuman RK, Rinaldi W. Hypertriglyceridemic waist and metabolic abnormalities in Brazilian schoolchildren. PLoS One. 2014;9:e111724. doi: 10.1371/journal.pone.0111724. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 8.Hobkirk JP, King RF, Gately P, Pemberton P, Smith A, Barth JH, Harman N, Davies I, Carroll S. The predictive ability of triglycerides and waist (hypertriglyceridemic waist) in assessing metabolic triad change in obese children and adolescents. Metab Syndr Relat Disord. 2013;11:336–42. doi: 10.1089/met.2012.0152. [DOI] [PubMed] [Google Scholar]
  • 9.Rees MG, Raimondo A, Wang J, Ban MR, Davis MI, Barrett A, Ranft J, Jagdhuhn D, Waterstradt R, Baltrusch S, Simeonov A, Collins FS, Hegele RA, Gloyn AL. Inheritance of rare functional GCKR variants and their contribution to triglyceride levels in families. Hum Mol Genet. 2014;23:5570–8. doi: 10.1093/hmg/ddu269. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 10.Lee BJ, Kim JY. Identification of type 2 diabetes risk factors using phenotypes consisting of anthropometry and triglycerides based on machine learning. IEEE J Biomed Health Inform. 2016;20:39–46. doi: 10.1109/JBHI.2015.2396520. [DOI] [PubMed] [Google Scholar]
  • 11.Han KJ, Lee SY, Kim NH, Chae HB, Lee TH, Jang CM, Yoo KM, Park HJ, Lee MK, Jeon WS, Park SE, Park CY, Lee WY, Oh KW, Park SW, Rhee EJ. Increased risk of diabetes development in subjects with the hypertriglyceridemic waist phenotype: a 4-year longitudinal study. Endocrinol Metab (Seoul) 2014;29:514–21. doi: 10.3803/EnM.2014.29.4.514. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 12.Foucan L, Maimaitiming S, Larifla L, Hedreville S, Deloumeaux J, Joannes MO, Blanchet-Deverly A, Velayoudom-Cephise FL, Aubert R, Salamon R, Donnet JP, Fumeron F. Adiponectin gene variants, adiponectin isoforms and cardiometabolic risk in type 2 diabetic patients. J Diabetes Investig. 2014;5:192–8. doi: 10.1111/jdi.12133. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 13.Carlsson AC, Riserus U, Arnlov J. Hypertriglyceridemic waist phenotype is associated with decreased insulin sensitivity and incident diabetes in elderly men. Obesity (Silver Spring) 2014;22:526–9. doi: 10.1002/oby.20434. [DOI] [PubMed] [Google Scholar]
  • 14.Yu W, Hu C, Jia W. Genetic advances of type 2 diabetes in Chinese populations. J Diabetes. 2012;4:213–20. doi: 10.1111/j.1753-0407.2012.00225.x. [DOI] [PubMed] [Google Scholar]
  • 15.Reisin E, Alpert MA. Definition of the metabolic syndrome: current proposals and controversies. Am J Med Sci. 2005;330:269–72. doi: 10.1097/00000441-200512000-00003. [DOI] [PubMed] [Google Scholar]
  • 16.Al-Lawati JA, Barakat NM, Al-Lawati AM, Mohammed AJ. Optimal cut-points for body mass index, waist circumference and waist-to-hip ratio using the Framingham coronary heart disease risk score in an Arab population of the Middle East. Diab Vasc Dis Res. 2008;5:304–9. doi: 10.3132/dvdr.2008.044. [DOI] [PubMed] [Google Scholar]
  • 17.Yu Z, Sun L, Qi Q, Wu H, Lu L, Liu C, Li H, Lin X. Hypertriglyceridemic waist, cytokines and hyperglycaemia in Chinese. Eur J Clin Invest. 2012;42:1100–11. doi: 10.1111/j.1365-2362.2012.02702.x. [DOI] [PubMed] [Google Scholar]
  • 18.Cantin B, Lamarche B, Despres JP, Dagenais GR. Does correction of the friedewald formula using lipoprotein (a) change our estimation of ischemic heart disease risk? The Quebec Cardiovascular Study. Atherosclerosis. 2002;163:261–7. doi: 10.1016/s0021-9150(02)00034-5. [DOI] [PubMed] [Google Scholar]
  • 19.Pouliot MC, Despres JP, Lemieux S, Moorjani S, Bouchard C, Tremblay A, Nadeau A, Lupien PJ. Waist circumference and abdominal sagittal diameter: best simple anthropometric indexes of abdominal visceral adipose tissue accumulation and related cardiovascular risk in men and women. Am J Cardiol. 1994;73:460–8. doi: 10.1016/0002-9149(94)90676-9. [DOI] [PubMed] [Google Scholar]
  • 20.Lamarche B, Tchernof A, Moorjani S, Cantin B, Dagenais GR, Lupien PJ, Despres JP. Small, dense low-density lipoprotein particles as a predictor of the risk of ischemic heart disease in men. Prospective results from the Quebec Cardiovascular Study. Circulation. 1997;95:69–75. doi: 10.1161/01.cir.95.1.69. [DOI] [PubMed] [Google Scholar]
  • 21.Bardini G, Dicembrini I, Pala L, Cresci B, Rotella CM. Hypertriglyceridaemic waist phenotype and beta-cell function in subjects with normal and impaired glucose tolerance. Diabet Med. 2011;28:1229–33. doi: 10.1111/j.1464-5491.2011.03332.x. [DOI] [PubMed] [Google Scholar]
  • 22.Sakurai M, Kobayashi J, Takeda Y, Nagasawa SY, Yamakawa J, Moriya J, Mabuchi H, Nakagawa H. Sex differences in associations among obesity, metabolic abnormalities, and chronic kidney disease in Japanese men and women. J Epidemiol. 2016;26:440–6. doi: 10.2188/jea.JE20150208. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 23.Van Schaftingen E. A protein from rat liver confers to glucokinase the property of being antagonistically regulated by fructose 6-phosphate and fructose 1-phosphate. Eur J Biochem. 1989;179:179–84. doi: 10.1111/j.1432-1033.1989.tb14538.x. [DOI] [PubMed] [Google Scholar]
  • 24.Agius L, Peak M, Van Schaftingen E. The regulatory protein of glucokinase binds to the hepatocyte matrix, but, unlike glucokinase, does not translocate during substrate stimulation. Biochem J. 1995;309:711–3. doi: 10.1042/bj3090711. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 25.Sparso T, Andersen G, Nielsen T, Burgdorf KS, Gjesing AP, Nielsen AL, Albrechtsen A, Rasmussen SS, Jorgensen T, Borch-Johnsen K, Sandbaek A, Lauritzen T, Madsbad S, Hansen T, Pedersen O. The GCKR rs780094 polymorphism is associated with elevated fasting serum triacylglycerol, reduced fasting and OGTTrelated insulinaemia, and reduced risk of type 2 diabetes. Diabetologia. 2008;51:70–5. doi: 10.1007/s00125-007-0865-z. [DOI] [PubMed] [Google Scholar]
  • 26.Takeuchi F, Katsuya T, Chakrewarthy S, Yamamoto K, Fujioka A, Serizawa M, Fujisawa T, Nakashima E, Ohnaka K, Ikegami H, Sugiyama T, Nabika T, Kasturiratne A, Yamaguchi S, Kono S, Takayanagi R, Yamori Y, Kobayashi S, Ogihara T, de Silva A, Wickremasinghe R, Kato N. Common variants at the GCK, GCKR, G6PC2-ABCB11 and MTNR1B loci are associated with fasting glucose in two Asian populations. Diabetologia. 2010;53:299–308. doi: 10.1007/s00125-009-1595-1. [DOI] [PubMed] [Google Scholar]
  • 27.Onuma H, Tabara Y, Kawamoto R, Shimizu I, Kawamura R, Takata Y, Nishida W, Ohashi J, Miki T, Kohara K, Makino H, Osawa H. The GCKR rs780094 polymorphism is associated with susceptibility of type 2 diabetes, reduced fasting plasma glucose levels, increased triglycerides levels and lower HOMA-IR in Japanese population. J Hum Genet. 2010;55:600–4. doi: 10.1038/jhg.2010.75. [DOI] [PubMed] [Google Scholar]
  • 28.Voight BF, Scott LJ, Steinthorsdottir V, Morris AP, Dina C, Welch RP, Zeggini E, Huth C, Aulchenko YS, Thorleifsson G, McCulloch LJ, Ferreira T, Grallert H, Amin N, Wu G, Willer CJ, Raychaudhuri S, McCarroll SA, Langenberg C, Hofmann OM, Dupuis J, Qi L, Segre AV, van Hoek M, Navarro P, Ardlie K, Balkau B, Benediktsson R, Bennett AJ, Blagieva R, Boerwinkle E, Bonnycastle LL, Bengtsson BK, Bravenboer B, Bumpstead S, Burtt NP, Charpentier G, Chines PS, Cornelis M, Couper DJ, Crawford G, Doney AS, Elliott KS, Elliott AL, Erdos MR, Fox CS, Franklin CS, Ganser M, Gieger C, Grarup N, Green T, Griffin S, Groves CJ, Guiducci C, Hadjadj S, Hassanali N, Herder C, Isomaa B, Jackson AU, Johnson PR, Jorgensen T, Kao WH, Klopp N, Kong A, Kraft P, Kuusisto J, Lauritzen T, Li M, Lieverse A, Lindgren CM, Lyssenko V, Marre M, Meitinger T, Midthjell K, Morken MA, Narisu N, Nilsson P, Owen KR, Payne F, Perry JR, Petersen AK, Platou C, Proenca C, Prokopenko I, Rathmann W, Rayner NW, Robertson NR, Rocheleau G, Roden M, Sampson MJ, Saxena R, Shields BM, Shrader P, Sigurdsson G, Sparso T, Strassburger K, Stringham HM, Sun Q, Swift AJ, Thorand B, Tichet J, Tuomi T, van Dam RM, van Haeften TW, van Herpt T, van Vliet-Ostaptchouk JV, Walters GB, Weedon MN, Wijmenga C, Witteman J, Bergman RN, Cauchi S, Collins FS, Gloyn AL, Gyllensten U, Hansen T, Hide WA, Hitman GA, Hofman A, Hunter DJ, Hveem K, Laakso M, Mohlke KL, Morris AD, Palmer CN, Pramstaller PP, Rudan I, Sijbrands E, Stein LD, Tuomilehto J, Uitterlinden A, Walker M, Wareham NJ, Watanabe RM, Abecasis GR, Boehm BO, Campbell H, Daly MJ, Hattersley AT, Hu FB, Meigs JB, Pankow JS, Pedersen O, Wichmann HE, Barroso I, Florez JC, Frayling TM, Groop L, Sladek R, Thorsteinsdottir U, Wilson JF, Illig T, Froguel P, van Duijn CM, Stefansson K, Altshuler D, Boehnke M, McCarthy MI. Twelve type 2 diabetes susceptibility loci identified through large-scale association analysis. Nat Genet. 2010;42:579–89. doi: 10.1038/ng.609. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 29.Wang J, Zhang J, Shen J, Hu D, Yan G, Liu X, Xu X, Pei L, Li Y, Sun C. Association of KCNQ1 and KLF14 polymorphisms and risk of type 2 diabetes mellitus: a global meta-analysis. Hum Immunol. 2014;75:342–7. doi: 10.1016/j.humimm.2014.01.008. [DOI] [PubMed] [Google Scholar]
  • 30.Tan S, Wang J, Cao L, Guo Z, Wang Y. Positive effect of exercise training at maximal fat oxidation intensity on body composition and lipid metabolism in overweight middle-aged women. Clin Physiol Funct Imaging. 2016;36:225–30. doi: 10.1111/cpf.12217. [DOI] [PubMed] [Google Scholar]

Articles from International Journal of Clinical and Experimental Pathology are provided here courtesy of e-Century Publishing Corporation

RESOURCES